HUT78070A - Eljárás humán inzulin előállítására - Google Patents

Eljárás humán inzulin előállítására

Info

Publication number
HUT78070A
HUT78070A HU9800292A HU9800292A HUT78070A HU T78070 A HUT78070 A HU T78070A HU 9800292 A HU9800292 A HU 9800292A HU 9800292 A HU9800292 A HU 9800292A HU T78070 A HUT78070 A HU T78070A
Authority
HU
Hungary
Prior art keywords
human insulin
generation
folded
polypeptide
new
Prior art date
Application number
HU9800292A
Other languages
English (en)
Other versions
HU223718B1 (hu
Inventor
Marian Gorecki
Jacob R. Hartman
Simona Mendelovitz
Original Assignee
Bio-Technology General Corp.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22243290&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUT78070(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bio-Technology General Corp. filed Critical Bio-Technology General Corp.
Priority to HU9800292A priority Critical patent/HU223718B1/hu
Publication of HUT78070A publication Critical patent/HUT78070A/hu
Publication of HU223718B1 publication Critical patent/HU223718B1/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1136—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by reversible modification of the secondary, tertiary or quarternary structure, e.g. using denaturating or stabilising agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Obesity (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
HU9800292A 1994-12-29 1994-12-29 Eljárás humán inzulin előállítására, proinzulin-tartalmú hibridpolipeptid expressziójából kiindulva HU223718B1 (hu)

Priority Applications (1)

Application Number Priority Date Filing Date Title
HU9800292A HU223718B1 (hu) 1994-12-29 1994-12-29 Eljárás humán inzulin előállítására, proinzulin-tartalmú hibridpolipeptid expressziójából kiindulva

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9800292A HU223718B1 (hu) 1994-12-29 1994-12-29 Eljárás humán inzulin előállítására, proinzulin-tartalmú hibridpolipeptid expressziójából kiindulva
PCT/US1994/013268 WO1996020724A1 (en) 1994-12-29 1994-12-29 Generation of human insulin

Publications (2)

Publication Number Publication Date
HUT78070A true HUT78070A (hu) 1999-08-30
HU223718B1 HU223718B1 (hu) 2004-12-28

Family

ID=22243290

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9800292A HU223718B1 (hu) 1994-12-29 1994-12-29 Eljárás humán inzulin előállítására, proinzulin-tartalmú hibridpolipeptid expressziójából kiindulva

Country Status (16)

Country Link
EP (1) EP0871474B2 (hu)
JP (1) JP4624495B2 (hu)
AT (1) ATE350053T1 (hu)
AU (1) AU698872B2 (hu)
BR (1) BR9408638A (hu)
CA (1) CA2208095C (hu)
CZ (1) CZ290079B6 (hu)
DE (2) DE69434909T3 (hu)
DK (1) DK0871474T4 (hu)
ES (1) ES2279510T5 (hu)
HK (1) HK1013594A1 (hu)
HU (1) HU223718B1 (hu)
NZ (1) NZ279002A (hu)
PL (1) PL180818B1 (hu)
PT (1) PT871474E (hu)
WO (1) WO1996020724A1 (hu)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19735711C2 (de) 1997-08-18 2001-04-26 Aventis Pharma Gmbh Verfahren zur Herstellung eines Vorläufers von Insulin oder Insulinderivaten mit korrekt verbundenen Cystinbrücken
EP1066328B1 (en) * 1998-03-31 2008-09-17 Tonghua Gantech Biotechnology Ltd. Chimeric protein containing an intramolecular chaperone-like sequence and its application to insulin production
JP3406244B2 (ja) 1999-04-30 2003-05-12 伊藤ハム株式会社 新規な融合蛋白質からの組み換えインスリンの製造方法
EP1265630B1 (en) 2000-03-24 2006-06-07 Genentech, Inc. Use of insulin for the treatment of cartilagenous disorders
US20040037828A1 (en) 2002-07-09 2004-02-26 Bar-Ilan University Methods and pharmaceutical compositions for healing wounds
AU2001284364B2 (en) 2000-07-31 2006-09-28 Bar Ilan University Methods and pharmaceutical compositions for healing wounds
US7312192B2 (en) * 2001-09-07 2007-12-25 Biocon Limited Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
PL212317B1 (pl) 2003-01-31 2012-09-28 Organon Nv Sposób izolacji bialka zawierajacego wiazania disulfidowe w natywnej konformacji
WO2005013885A2 (en) 2003-08-07 2005-02-17 Healor Ltd. Pharmaceutical compositions and methods for accelerating wound healing
WO2012015692A2 (en) * 2010-07-28 2012-02-02 Smartcells, Inc. Recombinantly expressed insulin polypeptides and uses thereof
WO2012048856A1 (en) 2010-10-12 2012-04-19 Glucometrix Pvs Gmbh Proinsulin with helper sequence
WO2012098009A1 (en) 2011-01-21 2012-07-26 Glucometrix Ag Chimeric polypeptide comprising a membrane protein and an insulin precursor
WO2013149729A2 (en) 2012-04-04 2013-10-10 Glucometrix Ag Proinsulin with enhanced helper sequence
CA2866491A1 (en) * 2014-10-02 2016-04-02 Clay Purdy Synthetic acid compositions and uses thereof
JP2018531007A (ja) * 2015-09-24 2018-10-25 ハンミ ファーマシューティカル カンパニー リミテッド インスリンの製造方法
PL239062B1 (pl) * 2016-01-22 2021-11-02 Inst Biotechnologii I Antybiotykow Sposób wytwarzania insuliny i jej pochodnych
US11230585B2 (en) 2016-09-06 2022-01-25 Chemical & Biopharmaceutical Laboratories Of Patra Proinsulin derivatives
US20210230659A1 (en) * 2018-06-18 2021-07-29 Unichem Laboratories Ltd Leader Sequence for Higher Expression of Recombinant Proteins
WO2020069040A1 (en) 2018-09-25 2020-04-02 Amphastar Pharmaceuticals, Inc. Highly purified recombinant human insulin (rhi) api and methods of producing the same
CN113527505A (zh) * 2020-04-15 2021-10-22 博锐生物科技有限公司 一种多肽和包含该多肽的药物组合物以及它们的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4430266A (en) * 1980-11-28 1984-02-07 Eli Lilly And Company Process for producing an insulin precursor
DK129385A (da) * 1985-03-22 1986-09-23 Novo Industri As Peptider og fremstilling deraf
US5342921A (en) * 1985-03-28 1994-08-30 Chiron Corporation Superoxide dismutase fusion polypeptides for expression of mammalian proteins
ATE63757T1 (de) † 1985-03-28 1991-06-15 Chiron Corp Expression durch verwendung von fusionsgenen fuer proteinproduktion.
DE3901719A1 (de) * 1989-01-21 1990-07-26 Hoechst Ag Verfahren zur herstellung eines insulinvorlaeufers
DE3901718A1 (de) * 1989-01-21 1990-07-26 Hoechst Ag Verfahren zur renaturierung falscher rekombinanten von insulinvorlaeufern
US5126249A (en) * 1989-05-09 1992-06-30 Eli Lilly And Company Enzymatic removal of a protein amino-terminal sequence
US5227293A (en) * 1989-08-29 1993-07-13 The General Hospital Corporation Fusion proteins, their preparation and use
IL104727A (en) * 1992-02-18 1997-01-10 Lilly Co Eli Selective removal of n-terminal extensions from folded insulin precursors using dipeptidyl-aminopeptidase-1
DE19701167A1 (de) * 1997-01-15 1998-07-23 Siemens Ag Chipkarte

Also Published As

Publication number Publication date
DK0871474T3 (da) 2007-05-07
BR9408638A (pt) 2004-09-21
ES2279510T3 (es) 2007-08-16
CA2208095C (en) 2006-11-28
NZ279002A (en) 1999-02-25
AU698872B2 (en) 1998-11-12
ES2279510T5 (es) 2012-01-19
AU1550095A (en) 1996-07-24
EP0871474A1 (en) 1998-10-21
DE69434909T2 (de) 2007-08-09
DK0871474T4 (da) 2012-01-09
JP4624495B2 (ja) 2011-02-02
DE69434909T3 (de) 2012-02-09
WO1996020724A1 (en) 1996-07-11
CZ290079B6 (cs) 2002-05-15
ATE350053T1 (de) 2007-01-15
EP0871474A4 (en) 2004-08-18
PT871474E (pt) 2007-02-28
DE95907193T1 (de) 2005-02-10
JPH10511849A (ja) 1998-11-17
CA2208095A1 (en) 1996-07-11
DE69434909D1 (de) 2007-02-15
EP0871474B2 (en) 2011-09-21
HU223718B1 (hu) 2004-12-28
EP0871474B1 (en) 2007-01-03
HK1013594A1 (en) 1999-09-03
PL180818B1 (pl) 2001-04-30
CZ203197A3 (cs) 1998-09-16
PL321039A1 (en) 1997-11-24

Similar Documents

Publication Publication Date Title
HUT78070A (hu) Eljárás humán inzulin előállítására
HK1049022A1 (zh) 生產hcv包膜蛋白的重組
HUT54213A (en) Process for the enzymatic removal of n-terminal sequence of proteins
GR3026230T3 (en) Expression of recombinant polypeptides with improved purification
HK1008021A1 (en) Growth hormone receptor
WO1995003405A3 (en) Enzymatic method for modification of recombinant polypeptides
EP0499990A3 (en) Method for producing cysteine-free peptides
GB2008123A (en) Method of means for microbial polypeptide expression
ES2124295T3 (es) Expresion y purificacion de factor tisular soluble recombinante.
EP1005526A4 (en) DIRECT EXPRESSION OF PEPTIDES IN CULTURAL MEDIUM.
EP0759067A4 (en) TRANSFORMING GROWTH FACTOR ALPHA H1
NZ510385A (en) E. coli enterotoxin II signal peptide and a microorganism expressing a fusion protein of the MST peptide and a heterologous protein, such as human growth hormone
MC1623A1 (fr) Procede de production d'un polypeptide
HUT63652A (en) Process for producing cd44 surface protein variants, dna sequences encoding them and antibodies against them, as well as their application in diagnosis and therapy
EP0269455A3 (en) Highly purified fused protein comprising human ige fc fragment and production thereof
AU7542187A (en) Light inducible promoter
ATE224403T1 (de) Verwendung von kaseinfragmenten als wachstumerförderer
EP0305063A3 (en) A process for production of c-terminal alpha-amide peptides
HUT43105A (en) Process for producing d-amino-acid-oxidase
HUP9902550A2 (hu) Eljárások neuropátiás fájdalom prosaposinszármazék peptidekkel történő enyhítésére

Legal Events

Date Code Title Description
HFG4 Patent granted, date of granting

Effective date: 20041028